These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28859784)

  • 1. Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy.
    Leyva F; Zegard A; Acquaye E; Gubran C; Taylor R; Foley PWX; Umar F; Patel K; Panting J; Marshall H; Qiu T
    J Am Coll Cardiol; 2017 Sep; 70(10):1216-1227. PubMed ID: 28859784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy.
    Leyva F; Zegard A; Umar F; Taylor RJ; Acquaye E; Gubran C; Chalil S; Patel K; Panting J; Marshall H; Qiu T
    Europace; 2018 Nov; 20(11):1804-1812. PubMed ID: 29697764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Specific Differences in Survival and Heart Failure Hospitalization After Cardiac Resynchronization Therapy With or Without Defibrillation.
    Leyva F; Qiu T; Zegard A; McNulty D; Evison F; Ray D; Gasparini M
    J Am Heart Assoc; 2019 Nov; 8(22):e013485. PubMed ID: 31718445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy.
    Leyva F; Taylor RJ; Foley PW; Umar F; Mulligan LJ; Patel K; Stegemann B; Haddad T; Smith RE; Prasad SK
    J Am Coll Cardiol; 2012 Oct; 60(17):1659-67. PubMed ID: 23021326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy.
    Doran B; Mei C; Varosy PD; Kao DP; Saxon LA; Feldman AM; DeMets D; Bristow MR
    JACC Heart Fail; 2021 Jun; 9(6):439-449. PubMed ID: 33992570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Anantha Narayanan M; Vakil K; Reddy YN; Baskaran J; Deshmukh A; Benditt DG; Adabag S
    JACC Clin Electrophysiol; 2017 Sep; 3(9):962-970. PubMed ID: 29759721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients.
    Abu Daya H; Alam MB; Adelstein E; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
    Heart Rhythm; 2014 Apr; 11(4):614-9. PubMed ID: 24462657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial recovery after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.
    Wang NC; Hussain A; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Shalaby AA; Voigt AH; Saba S
    Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12603. PubMed ID: 30267454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: The United States experience from 2007 to 2014.
    Saba S; McLaughlin T; He M; Althouse A; Mulukutla S; Hernandez I
    Heart Rhythm; 2019 Jul; 16(7):1065-1071. PubMed ID: 31004781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.
    Wang NC; Mezu-Chukwu U; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Shalaby AA; Voigt AH; Saba S
    Ann Noninvasive Electrocardiol; 2019 Jul; 24(4):e12641. PubMed ID: 30919524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure.
    Barra S; Providência R; Duehmke R; Boveda S; Marijon E; Reitan C; Borgquist R; Klug D; Defaye P; Sadoul N; Deharo JC; Sadien I; Patel K; Looi KL; Begley D; Chow AW; Le Heuzey JY; Agarwal S;
    Heart; 2017 May; 103(10):753-760. PubMed ID: 28104669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function and the long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation.
    Leyva F; Zegard A; Taylor R; Foley PWX; Umar F; Patel K; Panting J; Ferro CJ; Chalil S; Marshall H; Qiu T
    Pacing Clin Electrophysiol; 2019 Jun; 42(6):595-602. PubMed ID: 30873640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
    Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes after upgrading from pacemakers to cardiac resynchronization therapy.
    Leyva F; Zegard A; Patel K; Panting J; Marshall H; Qiu T
    Pacing Clin Electrophysiol; 2018 Mar; 41(3):290-298. PubMed ID: 29369371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.